Evaluation of 131I-anti-MIF mAb as a reporter for allograft rejection

Copyright © 2010 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 139(2011), 1 vom: 15. Apr., Seite 40-7
1. Verfasser: Liang, Ting (VerfasserIn)
Weitere Verfasser: Zhang, Chao, Song, Jing, Jiang, Shiqin, Hao, Jing, Hou, Guihua
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Antibodies, Monoclonal Iodine Radioisotopes Macrophage Migration-Inhibitory Factors
LEADER 01000naa a22002652 4500
001 NLM205411525
003 DE-627
005 20231223233910.0
007 cr uuu---uuuuu
008 231223s2011 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2010.12.017  |2 doi 
028 5 2 |a pubmed24n0685.xml 
035 |a (DE-627)NLM205411525 
035 |a (NLM)21273133 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Liang, Ting  |e verfasserin  |4 aut 
245 1 0 |a Evaluation of 131I-anti-MIF mAb as a reporter for allograft rejection 
264 1 |c 2011 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.06.2011 
500 |a Date Revised 28.03.2011 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2010 Elsevier Inc. All rights reserved. 
520 |a Finding a specific agent will be useful for monitoring allorejection in clinic. The macrophage migration inhibitory factor (MIF) was reported to be one of the major cytokines involved in allorejection. In this study, we evaluated whether (131)I-anti-MIF mAb could be an efficient imaging reporter for monitoring allorejection. (131)I-anti-MIF mAb or control (131)I-IgG was injected to skin allotransplantation mice and T/NT ratios were evaluated. The imaging changes of grafts were dynamically displayed by whole-body images. The results showed that up-regulation of MIF expression was found in allografts but not in isografts. During the whole progression of rejection, the T/NT ratio in the (131)I-anti-MIF mAb group was significantly higher than that in the (131)I-IgG group and markedly increased on the top of rejection. The graft-rejection could also be shown more clearly in the (131)I-anti-MIF mAb group by whole-body imaging. These results implied that (131)I-anti-MIF mAb may be a valid method for facilitating the development of protocols to monitor allorejection 
650 4 |a Journal Article 
650 7 |a Antibodies, Monoclonal  |2 NLM 
650 7 |a Iodine Radioisotopes  |2 NLM 
650 7 |a Macrophage Migration-Inhibitory Factors  |2 NLM 
700 1 |a Zhang, Chao  |e verfasserin  |4 aut 
700 1 |a Song, Jing  |e verfasserin  |4 aut 
700 1 |a Jiang, Shiqin  |e verfasserin  |4 aut 
700 1 |a Hao, Jing  |e verfasserin  |4 aut 
700 1 |a Hou, Guihua  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 139(2011), 1 vom: 15. Apr., Seite 40-7  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:139  |g year:2011  |g number:1  |g day:15  |g month:04  |g pages:40-7 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2010.12.017  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 139  |j 2011  |e 1  |b 15  |c 04  |h 40-7